MEDXF
Price
$2.02
Change
+$0.04 (+2.02%)
Updated
May 1 closing price
Capitalization
31.92M
58 days until earnings call
MKGAF
Price
$140.50
Change
-$3.40 (-2.36%)
Updated
May 2 closing price
Capitalization
76.59B
Ad is loading...

MEDXF vs MKGAF

Header iconMEDXF vs MKGAF Comparison
Open Charts MEDXF vs MKGAFBanner chart's image
Medexus Pharmaceuticals
Price$2.02
Change+$0.04 (+2.02%)
Volume$14.25K
Capitalization31.92M
Merck KGaA
Price$140.50
Change-$3.40 (-2.36%)
Volume$90
Capitalization76.59B
MEDXF vs MKGAF Comparison Chart
Loading...
MEDXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MEDXF vs. MKGAF commentary
May 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDXF is a Hold and MKGAF is a Hold.

Ad is loading...
COMPARISON
Comparison
May 04, 2025
Stock price -- (MEDXF: $2.02 vs. MKGAF: $140.50)
Brand notoriety: MEDXF and MKGAF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MEDXF: 79% vs. MKGAF: 11%
Market capitalization -- MEDXF: $31.92M vs. MKGAF: $76.59B
MEDXF [@Pharmaceuticals: Other] is valued at $31.92M. MKGAF’s [@Pharmaceuticals: Other] market capitalization is $76.59B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEDXF’s FA Score shows that 1 FA rating(s) are green whileMKGAF’s FA Score has 1 green FA rating(s).

  • MEDXF’s FA Score: 1 green, 4 red.
  • MKGAF’s FA Score: 1 green, 4 red.
According to our system of comparison, MEDXF is a better buy in the long-term than MKGAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEDXF’s TA Score shows that 3 TA indicator(s) are bullish.

  • MEDXF’s TA Score: 3 bullish, 2 bearish.

Price Growth

MEDXF (@Pharmaceuticals: Other) experienced а +4.66% price change this week, while MKGAF (@Pharmaceuticals: Other) price change was +1.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.04%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was -7.03%.

Reported Earning Dates

MEDXF is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.04% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKGAF($76.6B) has a higher market cap than MEDXF($31.9M). MEDXF has higher P/E ratio than MKGAF: MEDXF (26.67) vs MKGAF (20.96). MKGAF YTD gains are higher at: -7.297 vs. MEDXF (-16.356). MKGAF has higher annual earnings (EBITDA): 6.45B vs. MEDXF (14.6M). MKGAF has more cash in the bank: 1.72B vs. MEDXF (13.1M). MEDXF has less debt than MKGAF: MEDXF (70.1M) vs MKGAF (10.6B). MKGAF has higher revenues than MEDXF: MKGAF (22.3B) vs MEDXF (108M).
MEDXFMKGAFMEDXF / MKGAF
Capitalization31.9M76.6B0%
EBITDA14.6M6.45B0%
Gain YTD-16.356-7.297224%
P/E Ratio26.6720.96127%
Revenue108M22.3B0%
Total Cash13.1M1.72B1%
Total Debt70.1M10.6B1%
FUNDAMENTALS RATINGS
MEDXF vs MKGAF: Fundamental Ratings
MEDXF
MKGAF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
9372
SMR RATING
1..100
6370
PRICE GROWTH RATING
1..100
4459
P/E GROWTH RATING
1..100
571
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKGAF's Valuation (29) in the null industry is in the same range as MEDXF (61). This means that MKGAF’s stock grew similarly to MEDXF’s over the last 12 months.

MKGAF's Profit vs Risk Rating (72) in the null industry is in the same range as MEDXF (93). This means that MKGAF’s stock grew similarly to MEDXF’s over the last 12 months.

MEDXF's SMR Rating (63) in the null industry is in the same range as MKGAF (70). This means that MEDXF’s stock grew similarly to MKGAF’s over the last 12 months.

MEDXF's Price Growth Rating (44) in the null industry is in the same range as MKGAF (59). This means that MEDXF’s stock grew similarly to MKGAF’s over the last 12 months.

MEDXF's P/E Growth Rating (5) in the null industry is significantly better than the same rating for MKGAF (71). This means that MEDXF’s stock grew significantly faster than MKGAF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MEDXF
RSI
ODDS (%)
Bullish Trend 24 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 24 days ago
77%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
Bearish Trend 24 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 24 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 24 days ago
82%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
Bearish Trend about 1 month ago
82%
BollingerBands
ODDS (%)
Bullish Trend 24 days ago
70%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
MEDXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PBD11.160.23
+2.10%
Invesco Global Clean Energy ETF
DOL57.930.93
+1.63%
WisdomTree International LargeCp Div ETF
CEW18.130.22
+1.22%
WisdomTree Emerging Currency Strat ETF
IBDS24.08-0.04
-0.17%
iShares iBonds Dec 2027 Term Corp ETF
ETX18.05-0.03
-0.19%
EATON VANCE Municipal Income 2028 TERM TRUST

MEDXF and

Correlation & Price change

A.I.dvisor tells us that MEDXF and LBTSF have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEDXF and LBTSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDXF
1D Price
Change %
MEDXF100%
N/A
LBTSF - MEDXF
10%
Poorly correlated
N/A
MRMD - MEDXF
9%
Poorly correlated
+3.33%
MKGAF - MEDXF
7%
Poorly correlated
-2.36%
MCUJF - MEDXF
4%
Poorly correlated
N/A
MEDIF - MEDXF
2%
Poorly correlated
+7.36%
More

MKGAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKGAF has been loosely correlated with MKKGY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKGAF jumps, then MKKGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKGAF
1D Price
Change %
MKGAF100%
-2.36%
MKKGY - MKGAF
49%
Loosely correlated
+2.79%
AQST - MKGAF
19%
Poorly correlated
N/A
INDV - MKGAF
17%
Poorly correlated
+3.72%
EVO - MKGAF
17%
Poorly correlated
+1.42%
EBS - MKGAF
16%
Poorly correlated
N/A
More